127 related articles for article (PubMed ID: 37201765)
1. Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier.
Paul S; Guo Y; Wang C; Dun J; Calvin Sun C
Int J Pharm; 2023 Jun; 641():123041. PubMed ID: 37201765
[TBL] [Abstract][Full Text] [Related]
2. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation.
Paul S; Sun CC
Pharm Res; 2018 Mar; 35(6):113. PubMed ID: 29603027
[TBL] [Abstract][Full Text] [Related]
3. Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion.
Chen H; Paul S; Xu H; Wang K; Mahanthappa MK; Sun CC
Mol Pharm; 2020 Apr; 17(4):1387-1396. PubMed ID: 32134675
[TBL] [Abstract][Full Text] [Related]
4. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
Sun WJ; Aburub A; Sun CC
J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
[TBL] [Abstract][Full Text] [Related]
5. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
[TBL] [Abstract][Full Text] [Related]
6. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering.
Perumalla SR; Sun CC
J Pharm Sci; 2014 Apr; 103(4):1126-32. PubMed ID: 24515970
[TBL] [Abstract][Full Text] [Related]
7. A mesoporous silica based platform to enable tablet formulations of low dose drugs by direct compression.
Sun WJ; Aburub A; Sun CC
Int J Pharm; 2018 Mar; 539(1-2):184-189. PubMed ID: 29414125
[TBL] [Abstract][Full Text] [Related]
8. Uncovering the mechanism of Tenofovir amibufenamide fumarate punch sticking by combining direct compression experiment and computational simulation.
Zhao C; Wang X; Liu Y; Qin X; Chen W; Zhang J; Wu S; Gong J
Int J Pharm; 2024 Mar; 653():123813. PubMed ID: 38272192
[TBL] [Abstract][Full Text] [Related]
9. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression.
Hirschberg C; Sun CC; Rantanen J
J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089
[TBL] [Abstract][Full Text] [Related]
10. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach.
Yamashita H; Sun CC
Pharm Res; 2020 Jul; 37(8):153. PubMed ID: 32705421
[TBL] [Abstract][Full Text] [Related]
11. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
Capece M; Huang Z; Davé R
J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
[TBL] [Abstract][Full Text] [Related]
12. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
[TBL] [Abstract][Full Text] [Related]
13. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization.
Chen H; Aburub A; Sun CC
J Pharm Sci; 2019 Apr; 108(4):1396-1400. PubMed ID: 30448523
[TBL] [Abstract][Full Text] [Related]
14. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
Bejugam NK; Mutyam SK; Shankar GN
Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
[TBL] [Abstract][Full Text] [Related]
16. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer.
Yamashita H; Sun CC
Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid/saccharin for improvement of wettability and dissolution rate.
Hyun SM; Lee BJ; Abuzar SM; Lee S; Joo Y; Hong SH; Kang H; Kwon KA; Velaga S; Hwang SJ
Int J Pharm; 2019 Jan; 554():61-71. PubMed ID: 30347274
[TBL] [Abstract][Full Text] [Related]
18. A material sparing test to predict punch sticking during formulation development.
Simmons DM; Gierer DS
Drug Dev Ind Pharm; 2012 Sep; 38(9):1054-60. PubMed ID: 22181042
[TBL] [Abstract][Full Text] [Related]
19. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
[TBL] [Abstract][Full Text] [Related]
20. Trace polymer coated clarithromycin spherulites: Formation mechanism, improvement in pharmaceutical properties and development of high-drug-loading direct compression tablets.
Zhang X; Su M; Meng W; Zhao J; Huang M; Zhang J; Qian S; Gao Y; Wei Y
Int J Pharm; 2024 Apr; 654():123944. PubMed ID: 38403089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
